Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-21-021092

Chief Scientific Officer sold 800 shares at $45.00 ($36,000)

  • Chief Scientific Officer acquired 800 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hansen Gwenn · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-16 Exercise or conversion : show line 1 in the form +800 $7.26 $5,808 14,604 D
2021-03-16 Sale : show line 2 in the form −800 $45.00 $36,000 13,804 D
Open-market sales · 800 sh · avg $45.00 · $36,000

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-03-16 Exercise or conversion : show line 3 in the form Employee Stock Option (right to buy) −800 $7.26 2030-02-26 800 74,266 D
Loading xslF345X03/doc4.xml…